These findings corroborate and extend previous reports implicating ZMYND8 in breast cancer pathogenesis through diverse mechanisms, including metabolic reprogramming [30], enhancement of antioxidant defenses via NRF2 [59], and suppression of the cGAS–STING pathway [29]. This evidence concerns the gene ZMYND8 and breast carcinoma.